FDA NDC Directory · JSON-LD · Markdown

ACTEMRA

NDC 50242-137 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION, CONCENTRATE

Generic nametocilizumab
Labeler / ManufacturerGenentech, Inc.
Marketing categoryBiologic License Application · App BLA125276
Dosage form / routeINJECTION, SOLUTION, CONCENTRATE · INTRAVENOUS
Active ingredientsTOCILIZUMAB (400 mg/20mL)
Marketing started20100108
Package count1

External sources

Source: openFDA. Public-domain (CC0).